Status
Conditions
Treatments
About
The E-MOHS Trial is a randomized controlled trial evaluating whether active vibration plus transcutaneous electrical nerve stimulation reduces pain during local anesthetic infiltration in adults undergoing Mohs micrographic surgery or dermatologic excision.
Participants will be randomized to active vibration:TENS or sham TENS during the first local anesthetic administration. The primary outcome is patient-reported infiltration pain during active local anesthetic infiltration, measured using the 11-point Numeric Rating Scale.
Secondary outcomes include infiltration pain measured using a Visual Analog Scale, perioperative anxiety, participant satisfaction, willingness to reuse the device, operator-rated ease of use and sterile-field compatibility, blinding integrity, and adverse events.
Full description
Local anesthetic injection is a common source of pain and anxiety during Mohs micrographic surgery and dermatologic surgery. Physical counter-stimulation methods such as vibration and transcutaneous electrical nerve stimulation may reduce procedural pain through gate-control pain modulation.
The E-MOHS Trial is a parallel-group, two-arm, participant- and assessor-blinded randomized controlled trial. Adults undergoing Mohs micrographic surgery under local anesthesia, or dermatologic excision under local anesthesia in a pre-specified secondary population, will be enrolled on the day of surgery before the first local anesthetic administration.
Participants will be randomized 1:1 to active vibration:TENS or sham TENS. In the active arm, adhesive electrodes will be placed outside the sterile field and high-frequency transcutaneous electrical nerve stimulation will be applied during local anesthetic infiltration. A handheld vibration device will also be applied to intact skin adjacent to the injection site. In the sham arm, a fade-to-zero transient sham TENS device will be used to support blinding.
The primary endpoint is patient-reported pain of local anesthetic infiltration measured using the 11-point Numeric Rating Scale during active infiltration at the first anesthetic administration. Secondary outcomes include pain measured using a 100 mm Visual Analog Scale, perioperative anxiety, participant satisfaction, willingness to reuse the device, operator-rated ease of use and sterile-field compatibility, blinding integrity, and adverse events.
All research procedures occur during the scheduled surgical visit. No research-only follow-up visits are required. Adverse events will be monitored through the standard post-operative period as part of routine clinical care.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
90 participants in 2 patient groups
Loading...
Central trial contact
Ian Maher, MD; Andrew Fay
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal